US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy's Laboratories' API Cuernavaca plant at Mexico with Zero observation.

Earlier, USFDA completed audit of the company's Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, on June 16, 2017. The pharma major had been issued a Form 483 with one observation, which it is addressing.

Total volume of shares traded on the bourses today was lower by 32.87% to 164,040 compared with 22-day average volume of 244,369.

Shares of the company gained Rs 11.9, or 0.43%, to trade at Rs 2,758.00. The total volume of shares traded was 11,974 at the BSE (11.57 a.m., Friday).